Home 2019

Archives

FDA approves generic naloxone nasal spray

On April 19, the FDA approved the first generic naloxone hydrochloride nasal spray (Narcan). Read more at fda.gov.

FDA approves first targeted therapy for bladder cancer

On April 12, the FDA approved Balversa (erdafitinib) for adult patients with locally advanced or metastatic bladder cancer that has a susceptible genetic alteration...

Lack of access to antibiotics is global challenge

Although overuse of antibiotics gets most of the attention, many people in low-and middle-income countries die because they lack access to antibiotics, according to...

FDA approves new osteoporosis treatment

On April 9, the FDA approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of fracture. Read more at FDA.gov.

Sleeping pills and antihypertensive medications

Use of sleeping pills is associated with a higher number of antihypertensive drugs, according to a study in Geriatrics & Gerontology International. Read more at...

FDA approves new drug for multiple sclerosis

On March 26, the FDA approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome,...

FDA proposes new mammography amendments

On March 27, the FDA announced proposed amendments designed to provide more information for patients, including information about breast density. Read more at FDA.gov.

AHRQ new app improves efficiency, patient engagement

AHRQ’s free Question Builder App helps patients and caregivers prepare for medical appointments and maximize visit time. Read more at the Agency for Healthcare Research...

FDA approves first drug for postpartum depression

On March 19, the FDA approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression. Zulresso will be available only...
young adults opioids after surgery

Young adults’ use of opioids after surgery

Having a family member with persistent opioid use may be a risk factor for young adults (aged 13 to 21 years) continuing prescriptions long...
fda approves first interoperable insulin pump

FDA approves first interoperable insulin pump

On Feb. 14, the FDA approved Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2). This new type of insulin...
tobacco youth rises

Use of tobacco products by youth rises

According to a Feb. 11 statement by the FDA, about 4.9 million middle and high school students had used were current users (used in...
treatment acquired ttp

FDA approves first treatment for acquired TTP

On Feb. 6, the FDA approved Cablivi (caplacizumab-yhdp) injection, the first therapy indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment...

Most Recent Content

For Nurse Practitioners

Pregnant woman drinking coffee

Cup of Coffee Can Lessen Gestational Diabetes Risk

Pregnant mothers concerned about being able to safely enjoy their morning cup of coffee should be reassured by a recent University of Pennsylvania study...